BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2009
View Archived Issues
Enanta Pharmaceuticals claims new NS3/NS4A protease inhibitors for the treatment of HCV
Read More
MaxThera presents novel PPAT inhibitors for the treatment of bacterial infections
Read More
Novel PDE10A inhibitors in early development at BioTie Therapies as antipsychotics
Read More
Purdue Pharma discovers opioid receptor agonists and antagonists for the treatment of constipation
Read More
Novavax and Cadila launch joint venture in India
Read More
Merck & Co. and Portola sign worldwide license agreement for betrixaban
Read More
Spectrum submits response to FDA's complete response letter regarding sBLA for Zevalin
Read More
TRION reports new data on the mechanism of action of ertumaxomab
Read More
Discreet effect of rosiglitazone on vascular disease progression in prediabetic patients
Read More
Novel alpha7 nAChR agonist EVP-5141 improves cognitive ability in vivo
Read More
Vertex plans to sell rights to certain milestone payments related to telaprevir in Europe
Read More
AstraZeneca and MAP Pharmaceuticals terminate license agreement for unit dose budesonide
Read More
Addex achieves second preclinical milestone under PD collaboration with Merck & Co.
Read More
Sorafenib evaluated in different subtypes of recurrent or metastatic sarcoma
Read More
Sunitinib active in phase II non-GIST stromal tumor sarcomas trial
Read More
Cellceutix reports successful animal testing data for Kevetrin in lung cancer cell lines
Read More
Evotec enters fragment-based drug discovery agreement with Cubist
Read More
MediciNova proposes final protocol for phase II MN-221 trial in asthma
Read More
Can-Fite BioPharma receives approval to commence phase I/II trial for CF-102 in hepatitis C
Read More
Sunesis receives milestone payment from Biogen Idec for selection of Raf kinase inhibitor
Read More
PharmaMar releases statement regarding FDA oral session to discuss Yondelis
Read More
Hisamitsu to acquire Noven for USD 428 million in an all-cash tender offer
Read More
NovaMed signs agreements with Iroko and EUSA Pharma
Read More
PharmaSurgics completes phase I study of PXL-01 for postsurgical adhesion formation
Read More
